251 related articles for article (PubMed ID: 23675938)
1. Recent developments in computational prediction of HERG blockage.
Wang S; Li Y; Xu L; Li D; Hou T
Curr Top Med Chem; 2013; 13(11):1317-26. PubMed ID: 23675938
[TBL] [Abstract][Full Text] [Related]
2. In silico prediction of the chemical block of human ether-a-go-go-related gene (hERG) K+ current.
Inanobe A; Kamiya N; Murakami S; Fukunishi Y; Nakamura H; Kurachi Y
J Physiol Sci; 2008 Dec; 58(7):459-70. PubMed ID: 19032804
[TBL] [Abstract][Full Text] [Related]
3. Computational investigations of hERG channel blockers: New insights and current predictive models.
Villoutreix BO; Taboureau O
Adv Drug Deliv Rev; 2015 Jun; 86():72-82. PubMed ID: 25770776
[TBL] [Abstract][Full Text] [Related]
4. The cardiac hERG/IKr potassium channel as pharmacological target: structure, function, regulation, and clinical applications.
Thomas D; Karle CA; Kiehn J
Curr Pharm Des; 2006; 12(18):2271-83. PubMed ID: 16787254
[TBL] [Abstract][Full Text] [Related]
5. In silico prediction of hERG inhibition.
Jing Y; Easter A; Peters D; Kim N; Enyedy IJ
Future Med Chem; 2015; 7(5):571-86. PubMed ID: 25921399
[TBL] [Abstract][Full Text] [Related]
6. In silico predictions of hERG channel blockers in drug discovery: from ligand-based and target-based approaches to systems chemical biology.
Taboureau O; Jørgensen FS
Comb Chem High Throughput Screen; 2011 Jun; 14(5):375-87. PubMed ID: 21470179
[TBL] [Abstract][Full Text] [Related]
7. Predictive models for HERG channel blockers: ligand-based and structure-based approaches.
Thai KM; Ecker GF
Curr Med Chem; 2007; 14(28):3003-26. PubMed ID: 18220737
[TBL] [Abstract][Full Text] [Related]
8. A critical assessment of combined ligand- and structure-based approaches to HERG channel blocker modeling.
Du-Cuny L; Chen L; Zhang S
J Chem Inf Model; 2011 Nov; 51(11):2948-60. PubMed ID: 21902220
[TBL] [Abstract][Full Text] [Related]
9. A human ether-á-go-go-related (hERG) ion channel atomistic model generated by long supercomputer molecular dynamics simulations and its use in predicting drug cardiotoxicity.
Anwar-Mohamed A; Barakat KH; Bhat R; Noskov SY; Tyrrell DL; Tuszynski JA; Houghton M
Toxicol Lett; 2014 Nov; 230(3):382-92. PubMed ID: 25127758
[TBL] [Abstract][Full Text] [Related]
10. Collation, assessment and analysis of literature in vitro data on hERG receptor blocking potency for subsequent modeling of drugs' cardiotoxic properties.
Polak S; Wiśniowska B; Brandys J
J Appl Toxicol; 2009 Apr; 29(3):183-206. PubMed ID: 18988205
[TBL] [Abstract][Full Text] [Related]
11. Development of Safe Drugs: The hERG Challenge.
Kalyaanamoorthy S; Barakat KH
Med Res Rev; 2018 Mar; 38(2):525-555. PubMed ID: 28467598
[TBL] [Abstract][Full Text] [Related]
12. The interactions between hERG potassium channel and blockers.
Du L; Li M; You Q
Curr Top Med Chem; 2009; 9(4):330-8. PubMed ID: 19442204
[TBL] [Abstract][Full Text] [Related]
13. Predictive model for L-type channel inhibition: multichannel block in QT prolongation risk assessment.
Wiśniowska B; Mendyk A; Fijorek K; Glinka A; Polak S
J Appl Toxicol; 2012 Oct; 32(10):858-66. PubMed ID: 22761000
[TBL] [Abstract][Full Text] [Related]
14. [Lead compound optimization strategy(5) – reducing the hERG cardiac toxicity in drug development].
Zhou SB; Wang J; Liu H
Yao Xue Xue Bao; 2016 Oct; 51(10):1530-9. PubMed ID: 29932317
[TBL] [Abstract][Full Text] [Related]
15. An accurate and interpretable bayesian classification model for prediction of HERG liability.
Sun H
ChemMedChem; 2006 Mar; 1(3):315-22. PubMed ID: 16892366
[TBL] [Abstract][Full Text] [Related]
16. A multiscale simulation system for the prediction of drug-induced cardiotoxicity.
Obiol-Pardo C; Gomis-Tena J; Sanz F; Saiz J; Pastor M
J Chem Inf Model; 2011 Feb; 51(2):483-92. PubMed ID: 21250697
[TBL] [Abstract][Full Text] [Related]
17. Machine-learning technique, QSAR and molecular dynamics for hERG-drug interactions.
Das NR; Sharma T; Toropov AA; Toropova AP; Tripathi MK; Achary PGR
J Biomol Struct Dyn; 2023; 41(23):13766-13791. PubMed ID: 37021352
[TBL] [Abstract][Full Text] [Related]
18. Human ether-a-go-go-related gene channel blockers and its structural analysis for drug design.
Narayana Moorthy NS; Ramos MJ; Fernandes PA
Curr Drug Targets; 2013 Jan; 14(1):102-13. PubMed ID: 23061466
[TBL] [Abstract][Full Text] [Related]
19. Dynamics of hERG closure allow novel insights into hERG blocking by small molecules.
Schmidtke P; Ciantar M; Theret I; Ducrot P
J Chem Inf Model; 2014 Aug; 54(8):2320-33. PubMed ID: 25000969
[TBL] [Abstract][Full Text] [Related]
20. Indexing molecules for their hERG liability.
Rayan A; Falah M; Raiyn J; Da'adoosh B; Kadan S; Zaid H; Goldblum A
Eur J Med Chem; 2013 Jul; 65():304-14. PubMed ID: 23727540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]